Connect with us

Cannabis News

Are Psychedelics the Fountain of Youth?



Dr. Andrew Steele, a physics professor who has ventured into the field of biology, presents a fascinating perspective on longevity in his new book. He emphasizes that it’s not cancer or heart disease but aging that is the root cause of the most significant suffering and deaths worldwide. Dr. Steele proposes that by finding pharmacological remedies that target the cells responsible for degrading tissue function, we could unlock the potential for humans to live up to 200 years old.


A group of Harvard Medical School researchers has uncovered a groundbreaking finding that sheds new light on aging. In an unprecedented international study, the team discovered that alterations to the organization and regulation of DNA, known as epigenetics, can trigger aging in an organism, regardless of any genetic code changes. Their research revealed that a disruption in epigenetic information leads to aging in mice, and when the integrity of the epigenome is restored, the signs of aging are reversed.


According to David Sinclair, a professor of genetics at Harvard Medical School and co-director of the Paul F. Glenn Center for Biology of Aging Research, the recent discovery reinforces the notion that mammalian cells possess a backup copy of epigenetic software. By accessing this backup, it may be possible to rejuvenate aging cells and restore them to a more youthful and healthy state.


As reported in the Genetics Literacy Project, pursuing molecules capable of reversing the aging process is expected to attract tens of billions of dollars in research funding. Sinclair, who also heads Life Biosciences, a biotech firm that focuses on developing therapeutics to prevent, treat, and potentially reverse age-related diseases, is leading this effort to extend the human lifespan.


Psychedelics to Become a Significant Substance of Focus

The Longevity Science Foundation (LSF) made an exciting announcement at the Wonderland 2022 conference in November. The nonprofit organization, committed to funding research to promote a prolonged and healthier human lifespan, revealed a new funding initiative for psychedelics research. This new project is a collaboration between the LSF and PsyMed Ventures, a company focused on investments in the psychedelics sector.


The Longevity Science Foundation (LSF) reports that the use of psychedelics for mental health treatments is gaining momentum at an unprecedented pace. Compounds such as MDMA, ketamine, and psilocybin have demonstrated encouraging outcomes in treating PTSD, depression, and addiction. In addition, researchers have shown that ketamine and psilocybin may assist in regenerating neural connections, which could have far-reaching implications in the development of treatments for neurodegenerative disorders associated with aging, as per the LSF.


The LSF has pledged $1 billion in research funding, institutional support, and project financing over the next decade to support its mission to promote healthy human longevity. As part of this initiative, the foundation is looking to back psychedelics companies that are engaged in research aimed at managing, delaying, or even reversing age-related mental and brain diseases, investigating the mechanisms underlying the effects of psychedelic compounds, or other pioneering studies that have relevance to both the longevity and psychedelics fields.


The Healthy Longevity Medicine Society (HLMS), a partner of LSF, has set itself the goal of creating, coordinating, and promoting a comprehensive clinical research program that covers all facets of longevity medicine. The society intends to initiate various programs, such as the standardization of diagnostics and the creation of a clinical trial network.


Researchers have discovered drugs that can prolong the lifespan of animals, and one of LSF’s partners, rapamycin, has demonstrated the ability to prevent aging in mice. The drug has been found to reduce cognitive decline and delay the onset of Alzheimer’s disease, according to the LSF.


Scientists have discovered that a drug utilized to fight leukemia, when combined with a natural chemical substance derived from plants, exhibits the potential to lengthen human life. In addition, metformin, a drug that has been prescribed for diabetes for decades, is also demonstrating promise in the field of lifespan extension research.


Psychedelic therapy is finally getting recognition as a legitimate treatment option.

The executive coordinator of the LSF, Garri Zmudze, emphasizes the importance of mental health in longevity, stating that a healthy mind is just as crucial as a healthy body. The LSF’s funding of psychedelic research contributes to a growing body of knowledge transforming brain health and longevity.


Psychedelics researchers are exploring the potential role of psychedelics in extending life by examining their effects on neurons. The brain’s ability to change throughout life, known as neuroplasticity, is thought to be a critical component of life extension. Neuroplasticity involves changes in cell structure, structural plasticity, and alterations in the efficacy of synaptic transmission, also known as functional plasticity.


The ability of psychedelics to repair atrophied neurons, which occurs in depressed patients, results in improved synaptic connections or cell-to-cell communication. Experimental studies with LSD, ayahuasca, and psilocybin in placebo-controlled settings have shown positive results in reducing symptoms of depression, anxiety, and addiction after just one or two doses, with measurable effects lasting between three weeks and six months. Researchers believe that the persistence of psychological effects beyond the presence of the substance in the blood suggests a biological adaptation.


Researchers have suggested that psychedelics may have an anti-aging effect, albeit more related to personality changes. With up to 20% of the world’s population projected to be over 60 years old by 2050, research into aging is a critical scientific pursuit. However, the ultimate goal remains unclear: will the research lead to therapies to prevent diseases or directly target extending lifespan?


Sinclair has predicted that reversing human aging may happen as soon as 2025. Reportedly, psychedelic businesses are showing interest in the work of Sinclair, who has secured a remarkable $158 million in funding for Life Biosciences.



The psychedelics field has long been dedicated to discovering new therapies for medical issues that have yet to be addressed. Eleusis, a company in this industry, is focusing on the impact of aging and has discovered that LSD may help treat cognitive decline related to Alzheimer’s disease.


Their research indicates that aging is linked to decreased neuroplasticity and that age is a crucial risk factor for dementia. “The decline in neuroplasticity that comes with aging may play a significant role in the loss of synapses and neurons in Alzheimer’s disease,” Eleusis explains.





Source link

Cannabis News

So You Want to Grow Weed in Your Backyard or Garden, Do Ya?




grow weed in your backyard garden

If you’re venturing into growing cannabis for the first time, opting for outdoor cultivation might seem daunting initially. Achieving optimal yields often involves meticulous control over every aspect of the growth process, which outdoor conditions may not entirely provide.


However, with a solid grasp of the fundamentals, anyone can thrive in cultivating weeds in their backyard, garden, or greenhouse. While it demands consistent attention and precision, outdoor growing offers a natural, eco-friendly, and fulfilling approach.


Harnessing natural sunlight outdoors lends an undeniable charm to the cannabis plants. Consider the analogy of wine expertise: skilled sommeliers can discern a grape’s origin, soil type, and weather conditions from the nuances of a wine’s flavour profile.


Similarly, cultivating quality cannabis allows for a similar discernment. Outdoor growth infuses the plant with distinct attributes, resulting in a flavor and aroma profile unique to its environment. This method also facilitates the plant’s optimal growth potential, basking in the nourishment of natural sunlight.


Advantages of Garden Cultivation


The benefits of cultivating cannabis outdoors in a garden setting are plentiful:


Utilizes natural sunlight: When unhindered by clouds, the sun provides superior-quality light compared to even the most advanced and costly grow lights. Under its radiant glow, your plants will thrive, making outdoor growth an efficient and cost-effective method.


Cost-effective: Outdoor cultivation is remarkably inexpensive compared to setting up an indoor grow operation. Expenses for tents, lights, and ventilation systems can tally up to hundreds or even thousands of euros. Conversely, outdoor growing requires only soil, fertilizer, pots, cannabis seeds, and perhaps a watering can. Opting for outdoor cultivation can significantly reduce expenses.


Increased enjoyment: Growing a garden outside is, for a lot of people, a more enjoyable experience than working in a grow tent with artificial lighting. Cannabis grown outdoors has many of the same health advantages as gardening, which is widely known for its beneficial effects on both physical and mental health.


Outstanding results: Because of the large amount of room, sunlight, and length of the growth season, plants planted outdoors have the potential to develop to enormous sizes. Outside growing usually produces large crops.


Season-long harvests: If you grow auto-flowering cultivars with short life cycles outside, you can potentially harvest two or even three crops in one summer. This method is great for those with little area since it may produce a good quantity of buds by winter.


Reduced labor: Generally, outdoor cultivation requires less intensive labor compared to indoor growing, providing a more laid-back experience, assuming all goes well.


Tips for Outdoor Cannabis Cultivation


1. Ensure Adequate Sun Exposure

Your cannabis plants need full sunshine to stay healthy and vigorous. A minimum of six hours of direct sunshine each day and a minimum of twelve hours of light overall constitute optimal solar exposure. Since cannabis needs sunshine to survive, not enough exposure might hinder photosynthesis, which can result in stunted growth and lower harvests. Taking into account the sun’s fluctuating path across the sky, choose a planting spot that will provide steady sunshine for the duration of the growth season.


2. Choose Between Ground Planting and Pots, Considering Watering Methods

The decision to cultivate your cannabis in the ground or in pots significantly influences watering practices, plant size, and yield potential. Ground planting allows for extensive root expansion, fostering larger plants and potentially greater yields. However, it also subjects plants to the fluctuating conditions of weather and soil moisture.


Conversely, pot cultivation grants greater control over watering and soil conditions, particularly beneficial in areas with erratic weather patterns or poor soil quality. Over time, you’ll refine your approach based on local conditions. Notably, pot cultivation facilitates the flexibility to bring plants indoors when necessary, safeguarding them from sudden temperature drops or adverse weather conditions.


3. Understand Your Soil Composition

Healthy soil is essential to a flourishing garden. Prioritize soil that is high in organic matter, has good drainage, and is well-structured for enough aeration while cultivating cannabis. Additionally, to maximize the absorption of nutrients, strive for a pH level that is balanced, preferably falling between 5.8 and 6.5.


Plant death, stunted growth, and nutritional deficits can all be caused by inadequate soil conditions. Any gardening endeavor should start with a thorough soil study to find deficiencies and correct them with the right fertilizer, especially for delicate plants like cannabis.


4. Explore Natural Pest Management Techniques

Outdoor cannabis plants face significant threats from pests, posing risks to yield and plant vitality. Common invaders such as spider mites, aphids, and caterpillars can wreak havoc. However, given the consumption of cannabis products, harsh chemical solutions should be avoided.


Fortunately, numerous natural pest control strategies exist to safeguard your garden. Introducing beneficial insects like ladybugs and predatory mites can effectively regulate harmful insect populations. Additionally, practices like crop rotation and companion planting offer further protection. Regular monitoring and swift intervention often serve as the most effective preventive measures.


5. Master the Art of Cannabis Pruning

Cannabis pruning, although often underestimated, plays a pivotal role in outdoor cultivation. Thoughtful removal of leaves and branches can enhance light penetration and air circulation, promoting overall plant vigor and productivity. Pruning enables you to shape the plant, manage its size, and channel its energy toward producing abundant, robust buds. However, exercise restraint in pruning; excessive trimming can stress the plant and impede growth.


Bottom Line


Outdoor cannabis cultivation in a garden or backyard presents a cost-effective, enjoyable, and rewarding endeavor. By leveraging natural sunlight, understanding soil composition, employing natural pest management, and mastering cannabis pruning, growers can achieve optimal yields and high-quality harvests. Outdoor cultivation offers unique advantages, including reduced expenses compared to indoor setups, increased enjoyment from working in a natural environment, and the potential for impressive results due to ample space and sunlight. Furthermore, outdoor growing typically requires less labor, providing a more relaxed experience for growers. With careful attention to these key factors, outdoor cannabis cultivation can yield bountiful harvests of top-quality cannabis, making it a preferred choice for many enthusiasts.

Source link

Continue Reading

Cannabis News

Criminalizing Cannabis Doesn’t Work at All




marijuana usage rates legal vs non legal

Why criminalization doesn’t curtail consumption


The spirit of prohibition is rooted in the desire to restrict individuals from accessing certain substances or engaging in particular activities deemed harmful or undesirable by those in power. At its core, prohibition is a paternalistic approach that employs the threat of severe consequences, often in the form of state-sanctioned violence, to discourage and punish those who dare to defy the established rules. If we were to remove the veneer of governmental authority from this equation, the true nature of prohibition would be laid bare as a hostile and coercive scenario, where the individual’s autonomy is subjugated to the whims of the ruling class.


Proponents of prohibition argue that this looming threat of violence is a necessary evil, a means to an end in the quest to curtail consumption and send a clear message to impressionable youth that certain behaviors will not be tolerated. They claim that by instilling fear of legal repercussions, society can effectively deter individuals from engaging in prohibited activities, thereby protecting them from potential harm. “The law will punish you!” becomes the rallying cry of those who believe that the heavy hand of the state is the only way to maintain order and public health.


However, a recent Gallup poll has called into question the very foundation upon which the edifice of prohibition is built. The survey found that rates of marijuana use are nearly identical in states that have legalized the substance compared to those that continue to maintain its prohibition. This startling revelation suggests that criminalization has little impact on actually curbing consumption, challenging the long-held belief that the threat of punishment is an effective deterrent.


In light of this new evidence, it is time to ask ourselves: isn’t there a better way? If prohibition fails to achieve its stated goal of reducing substance use, while simultaneously perpetuating a system of violence and oppression, should we not seek alternative approaches that prioritize harm reduction, education, and individual liberty? The spirit of prohibition may be deeply entrenched in our society, but the cracks in its foundation are beginning to show, inviting us to imagine a future where the individual’s autonomy is respected and evidence-based policies prevail over fear-mongering and coercion.



The recent Gallup poll on marijuana use in the United States has shed new light on the effectiveness, or lack thereof, of drug prohibition. The survey, which involved interviews with 6,386 U.S. adults from November 30, 2023, to December 8, 2023, found that rates of marijuana use are nearly identical in states that have legalized the substance compared to those that continue to maintain its prohibition. This finding strikes at the heart of the argument that criminalization is necessary to curb drug consumption.


According to the poll, one in 10 American adults reported using marijuana 10 or more times in the past month, while one in five admitted to using cannabis at least once during the same period. When broken down by state legal status, the data revealed that 9.7 percent of adults identify as regular cannabis consumers in states that have enacted legalization, compared to 8.6 percent in non-legal states. This narrow gap in consumption rates suggests that criminalization has little impact on deterring use among American adults.


The poll also examined marijuana use across different age groups and regions. Interestingly, there were no significant differences in consumption rates between adults aged 18-29, 30-39, and 40-49, with all three age groups averaging around 12 percent regular use. The survey accounted for the various methods of marijuana consumption, including smoking, vaping, and consuming edibles, ensuring a comprehensive assessment of use patterns.


Perhaps most striking is the finding that the West region, which includes states like California, Oregon, and Washington that have established adult-use cannabis markets, has a slightly lower usage rate (10 percent) compared to the Middle Atlantic region (11 percent), where only Pennsylvania has maintained prohibition for adult use. This data further undermines the notion that legalization leads to increased consumption.


The Gallup poll provides compelling evidence that the criminalization of drug use has little to no impact on actual consumption rates. As the debate surrounding drug policy continues to evolve, these findings should serve as a catalyst for policymakers to reevaluate the efficacy of prohibition and explore alternative approaches that prioritize public health, harm reduction, and individual liberty over punitive measures that have proven ineffective in curbing substance use. The data speaks for itself: it is time to abandon the failed war on drugs and embrace evidence-based strategies that address the root causes of substance abuse while respecting the autonomy of individuals.



It’s a simple truth that has been consistently demonstrated throughout the history of drug prohibition: those who want to consume substances will find a way to do so, regardless of the legal status or societal stigma attached to their chosen intoxicant. Even during the height of the drug war, when draconian policies and harsh punishments were the norm, consumption rates never significantly declined. In fact, they often remained stable or even spiked in response to the increased pressure from law enforcement, highlighting the futility of attempting to control human behavior through brute force and intimidation.


The reality is that if someone wants to get high, they can and will find a way to do so. It’s a matter of networking and tapping into the right circles, and virtually anyone with a bit of determination and resourcefulness can gain access to illicit substances. Ironically, even playing into stereotypes can sometimes lead to success in this endeavor, as the black market thrives on the very prejudices and assumptions that society perpetuates.


But the larger point here is that drugs are an inextricable part of our society, woven into the fabric of human experience for millennia. From ancient rituals to modern-day experimentation, the desire to alter one’s consciousness has been a constant throughout history. It’s high time we recognize this reality and adjust our approach accordingly, rather than clinging to the misguided notion that we can somehow eradicate drug use through punishment and prohibition.


By keeping substances illegal, we create a host of other risks and problems that only serve to compound the harm associated with drug use. The unregulated nature of the black market means that users have no way of knowing the purity or potency of the substances they consume, leading to increased risk of overdose and other adverse health effects. Moreover, the criminalization of drug use perpetuates a cycle of stigma, marginalization, and incarceration that tears families and communities apart, while doing little to address the underlying causes of addiction and substance abuse.


It’s time for a paradigm shift in how we approach drug policy. Rather than futilely attempting to eliminate drug use through prohibition, we must acknowledge that intoxication is a part of the human experience and work to mitigate the harms associated with it through evidence-based strategies rooted in public health and harm reduction. By decriminalizing substance use and treating it as a matter of personal choice and individual liberty, we can create a society that is more compassionate, more just, and ultimately safer for all. Because at the end of the day, those who wanna smoke, will smoke – and it’s up to us to ensure that they can do so in a way that minimizes risk and maximizes well-being.



As we navigate the ever-shifting landscape of drug policy, it’s crucial to remain vigilant and aware of the potential pitfalls that lie ahead. In recent years, I’ve noticed a polar shift from the left to the right, a trend that, while bearable for now, carries with it the risk of veering too far into the dangerous territory of the “drug war.” It’s important to remember that it was through the lens of the “polar-right” that prohibition first laid its roots, and we must be cautious not to repeat the mistakes of the past.


As the debate surrounding cannabis legalization continues to evolve, it’s essential to scrutinize the policies being put forth and to recognize when they may not be in the best interest of the people. The proposed shift to Schedule-III, for example, is not the victory that many advocates have been fighting for. It’s not the true legalization that the cannabis community seeks, but rather a half-measure that fails to address the fundamental issues at play.


The people who have fought tirelessly for cannabis reform want nothing less than the recognition of their fundamental human right to grow, cultivate, sell, and gift this plant as they would any other commodity, like tomatoes. They seek a world where the government respects their autonomy and trusts them to make informed decisions about their own well-being, without the need for excessive regulation or control.


Instead, what we’re seeing is a government that seems intent on playing the pharmaceutical game, attempting to schedule cannabis in a way that would effectively remove it from the hands of the people and place it under the control of corporate interests. This is not the vision that the cannabis community has been fighting for, and it’s crucial that we recognize this fact and push back against any attempts to subvert the will of the people.


As we move forward, let us hold fast to the hope that the past will remain in the past, that the dark days of prohibition will fade away into the annals of history, and that the institutions that have long kept the gates of progress closed will wither and crumble.


Let us work together to build a future where the autonomy and liberty of the individual are respected, where evidence-based policies prevail over fear and stigma, and where the harms of the drug war are finally laid to rest.


May we learn from the mistakes of the past and forge a new path forward, one that values compassion, understanding, and the fundamental rights of all people.





Source link

Continue Reading

Cannabis News

Can Magic Mushrooms Make You Paranoid Like Weed Sometimes Does?




paranoia mushrooms psilocybin

As more and more studies explore the potential therapeutic benefits of psilocybin, the main hallucinogenic ingredient in magic mushrooms, encouraging results are being found for several ailments that do not respond well to traditional therapies. In spite of this, many people find it frightening to venture into the world of psychedelics.


Much like the old “reefer madness” hoax surrounding cannabis, psilocybin and other psychedelics are rapidly losing their stigma in society. There is less evidence to support the claim that psychedelic experiences always result in psychosis and other mental health problems.


Studies show that emergency room visits related to psilocybin use are exceedingly rare, with most negative effects stemming from factors like mindset, setting, and substance combinations, often resolving within a day.


While acknowledging the inherent risks in any medical intervention, recent research has focused on examining adverse effects associated with psilocybin therapy for anxiety and depression. A meta-analysis published in JAMA Psychiatry by researchers from the University of Georgia, Larkin University, and Palm Beach Atlantic University scrutinized double-blind clinical trials spanning from 1966 to 2023.


The findings identify anticipated adverse effects of psilocybin therapy for depression and anxiety, but notably, paranoia and transient thought disorders were reported infrequently compared to other symptoms.


Reflecting on Past Research to Shape the Future


The authors of a recent study on psilocybin treatment for depression and anxiety disorders commence by highlighting the existing body of research on the subject. They note that while previous clinical investigations have primarily focused on efficacy, there has been a notable absence of emphasis on the safety profile of psilocybin.


In order to analyze the side effects associated with therapeutic dosages of psilocybin in the treatment of depression and anxiety, researchers reviewed a large number of relevant publications. These studies included randomized clinical trials that compared psilocybin to placebo groups or other comparators. Furthermore, based on previous clinical data, the researchers divided the delivered dosages into three categories: low (1-3 mg), moderate (10-20 mg), and high (20-30 mg).


The analysis involved six distinct studies involving a collective total of 528 participants. Notably, participants typically experienced adverse effects either immediately or within 24 hours following psilocybin administration. Despite common misconceptions surrounding psilocybin and similar psychedelics, the study authors found no evidence linking psilocybin to the onset of paranoia or transient thought disorders, which are characterized by sudden psychotic symptoms.


Among the adverse effects observed across all six studies, headache (with an incidence ranging from 2% to 66%) and nausea (ranging from 4% to 48%) were consistently reported. Anxiety was documented in three of the studies, with incidence rates ranging from 4% to 26%. The authors also highlight that all adverse effects, except for elevated blood pressure, were estimated to occur in less than 50% of participants.


Psilocybin Induces Manageable Short-Term Side Effects with Prompt Resolution


In their discussion, researchers emphasize the necessity of summarizing the acute adverse effects of psilocybin in treating depression and anxiety for healthcare professionals. They highlight that understanding these effects is crucial for effective patient counseling. The study reveals a statistically significant occurrence of headache, nausea, anxiety, dizziness, and elevated blood pressure, which aligns with the expected side effects of serotonergic antidepressants due to psilocybin’s mechanism of action.


The research documents three instances of paranoia and transient thought disorder in high-dose psilocybin across 128 patients, with therapist or facilitator assistance likely mitigating potential complications. While the incidence of paranoia and transient thought disorder appears low, the study underscores the importance of exploring these adverse effects further.


Conclusively, the study finds that therapeutic doses of psilocybin generally result in tolerable acute adverse effects that typically subside within 24 to 48 hours. However, less common adverse effects like paranoia and prolonged visual perceptual effects merit attention.


The authors advocate for larger trials to comprehensively assess adverse effects, particularly in populations with concurrent health conditions. They also call for research focusing on medication efficacy, alternative treatments, and the role of licensed therapists in managing adverse effects.


They recommend that guidelines for monitoring acute adverse effects encompass headache, nausea, anxiety, dizziness, paranoia, blood pressure and heart rate fluctuations, visual perceptual changes, physical discomfort, and mood alterations at a minimum.


Shifting Perspectives on Psychedelics


The research of the therapeutic potential of psychedelics, notably psilocybin found in magic mushrooms, reveals that cultural attitudes are progressively changing. Psychedelics, formerly stigmatized and feared, are increasingly receiving recognized for their promise ability to address mental health issues that are resistant to traditional therapy. This paradigm change represents a break from old narratives that presented psychedelics as inherently hazardous and without therapeutic potential.


The changing way that society views psychedelics is reflected in the expanding body of research that examines their potential therapeutic uses with ever-greater rigor and detail. The potential of medicines like psilocybin to facilitate remarkable healing experiences is becoming increasingly recognized as scientific research reveals the processes underlying these effects. This new insight emphasizes the significance of taking a balanced approach to psychedelics, acknowledging both their therapeutic potential and concomitant hazards.


Within this evolving landscape, the role of healthcare professionals and researchers is pivotal in shaping informed discourse and evidence-based practices surrounding psychedelic therapy. By fostering open dialogue and disseminating accurate information, stakeholders can dispel myths and misconceptions while promoting responsible and ethical use of psychedelics in clinical settings. Furthermore, by advocating for robust regulatory frameworks and comprehensive training programs, professionals can ensure the safe and effective integration of psychedelics into mental health care.


It is critical to foster a climate of respect, empathy, and understanding surrounding the use of psychedelics as society works to move past the stigma. Through the adoption of a balanced viewpoint that recognizes the possible advantages as well as disadvantages of psychedelics, we may effectively utilize their therapeutic potential while preserving personal health. In the end, the movement toward psychedelic acceptance and de-stigmatization is a big step forward in the search for novel and all-encompassing methods of providing mental health care.


Bottom Line


As research continues to uncover the therapeutic potential of psychedelics, particularly psilocybin, societal attitudes are shifting away from stigmatization toward recognition of their promise in addressing mental health challenges. This evolving perspective, mirrored by an expanding body of rigorous research, emphasizes the importance of informed discourse, responsible use, and comprehensive regulatory frameworks to ensure the safe and effective integration of psychedelics into mental health care. By fostering understanding and respect for the potential benefits and risks of psychedelics, society can move toward a more holistic approach to mental health treatment.





Source link

Continue Reading


Copyright © 2021 The Art of MaryJane Media